Modern approaches to the management of patients with bronchoectasia ; Современные подходы к ведению пациентов с бронхоэктазией

Συγγραφείς: E. Kh. Anaev, Э. Х. Анаев

Πηγή: PULMONOLOGIYA; Том 30, № 1 (2020); 81-91 ; Пульмонология; Том 30, № 1 (2020); 81-91 ; 2541-9617 ; 0869-0189 ; 10.18093/0869-0189-2020-30-1

Θεματικοί όροι: первичная цилиарная дискинезия, etiology, diagnostics, multispiral computed tomography, mucoactive therapy, antimicrobial drugs, allergic bronchopulmonary aspergillosis, primary ciliary dyskinesia, этиология, диагностика, мультиспиральная компьютерная томография, мукоактивная терапия, антибактериальные препараты, аллергический бронхолегочный аспергиллез

Περιγραφή αρχείου: application/pdf

Relation: https://journal.pulmonology.ru/pulm/article/view/1286/988; Polverino E., Goeminne P.C., McDonnell M.J. et al. European Respiratory Society guidelines for the management of adult bronchiectasis. Eur. Respir. J. 2017; 50 (3): pii: 1700629. DOI:10.1183/13993003.00629-2017.; Pasteur M.C., Bilton D., Hill A.T. British Thoracic Society guidelines for non-CF bronchiectasis. Thorax. 2010; 65 (Suppl. 1): i1–58. DOI:10.1136/thx.2010.136119.; Chandrasekaran R., Mac Aogáin M., Chalmers J.D. et al. Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis. BMC. Pulm. Med. 2018; 18 (1): 83. DOI:10.1186/s12890-018-0638-0.; Чучалин А.Г., ред. Респираторная медицина: руководство в 3 т. 2-е изд., перераб. и доп. М.: Литтерра; 2017. Т. 1.; Quint J.K., Millett E.R., Joshi M. et al. Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study. Eur. Respir. J. 2016; 47 (1): 186–193. DOI:10.1183/13993003.01033-2015.; Contarini M., Finch S., Chalmers J.D. Bronchiectasis: a case-based approach to investigation and management. Eur. Respir. Rev. 2018; 27 (149): 180016. DOI:10.1183/16000617.0016-2018.; Altenburg J., Wortel K., van der Werf T.S., Boersma W.G. Non-cystic fibrosis bronchiectasis: clinical presentation, diagnosis and treatment, illustrated by data from a Dutch Teaching Hospital. Neth. J. Med. 2015; 73 (4): 147–154.; Smith M.P. Diagnosis and management of bronchiectasis. CMAJ. 2017; 189 (24): E828–835. DOI:10.1503/cmaj.160830.; Finch S., McDonnell M.J., Abo-Leyah H. et al. A comprehensive analysis of the impact of Pseudomonas aeruginosa colonization on prognosis in adult bronchiectasis. Ann. Am. Thorac. Soc. 2015; 12 (11): 1602–1611. DOI:10.1513/AnnalsATS.201506-333OC.; Shoemark A., Ozerovitch L., Wilson R. Aetiology in adult patients with bronchiectasis. Respir. Med. 2007; 101 (6): 1163–1170.; Pasteur M.C., Helliwell S.M., Houghton S.J. et al. An investigation into causative factors in patients with bronchiectasis. Am. J. Respir. Crit. Care. Med. 2000; 162 (4, Pt 1): 12771284. DOI:10.1164/ajrccm.162.4.9906120.; Зимина В.Н., Дегтярева С.Ю., Белобородова Е.Н. и др. Микобактериозы: современное состояние проблемы. Клиническая микробиология и антимикробная химиотерапия. 2017; 19 (4): 276–282. Доступно на: https://cyberleninka.ru/article/n/mikobakteriozy-sovremennoe-sostoyanie-problemy/viewer; Anwar G.A., McDonnell M.J., Worthy S.A. et al. Phenotyping adults with non-cystic fibrosis bronchiectasis: a prospective observational cohort study. Respir. Med. 2013; 107 (7): 1001–1007. DOI:10.1016/j.rmed.2013.04.013.; Lonni S., Chalmers J.D., Goeminne P.C. et al. Etiology of non-cystic fibrosis bronchiectasis in adults and its correlation to disease severity. Ann. Am. Thorac. Soc. 2015; 12 (12): 1764–1770. DOI:10.1513/AnnalsATS.201507-472OC.; Cartier Y., Kavanagh P.V., Johkoh T. et al. Bronchiectasis: accuracy of high-resolution CT in the differentiation of specific diseases. Am. J. Roentgenol. 1999; 173: 47–52.; Bush A., Floto R.A. Pathophysiology, causes and genetics of paediatric and adult bronchiectasis. Respirology. 2019; 24 (11): 1053–1062. DOI:10.1111/resp.13509.; Kousha M., Tadi R., Soubani A.O. Pulmonary aspergillosis: a clinical review. Eur. Respir. Rev. 2011; 20 (121): 156–174. DOI:10.1183/09059180.00001011.; Eaton T., Garrett J., Milne D. et al. Allergic bronchopulmonary aspergillosis in the asthma clinic. A prospective evaluation of CT in the diagnostic algorithm. Chest. 2000; 118(1): 66–72. DOI:10.1378/chest.118.1.66.; Stevens D.A., Moss R.B., Kurup V.P. et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis – state of the art: Cystic Fibrosis Foundation Consensus Conference. Clin. Infect. Dis. 2003; 37 (Suppl. 3): S225–264. DOI:10.1086/376525.; Kelly M.G., Murphy S., Elborn J.S. Bronchiectasis in secondary care: a comprehensive profile of a neglected disease. Eur. J. Intern. Med. 2003; 14 (8): 488–492. DOI:10.1016/j.ejim.2003.10.002.; Patterson K., Strek M.E. Allergic bronchopulmonary aspergillosis. Proc. Am. Thorac. Soc. 2010; 7 (3): 237–244. DOI:10.1513/pats.200908-086AL.; Patterson K.C., Strek M.E. Diagnosis and treatment of pulmonary aspergillosis syndromes. Chest. 2014; 146 (5): 1358–1368. DOI:10.1378/chest.14-0917.; Mitchell T.A., Hamilos D.L., Lynch D.A., Newell J.D. Distribution and severity of bronchiectasis in allergic bronchopulmonary aspergillosis (ABPA). J. Asthma. 2000; 37 (1): 65–72. DOI:10.3109/02770900009055429.; Greenberger P.A., Miller T.P., Roberts M., Smith L.L. Allergic bronchopulmonary aspergillosis in patients with and without evidence of bronchiectasis. Ann. Allergy. 1993; 70 (4): 333–338.; Patterson R., Greenberger P.A., Radin R.C., Roberts M. Allergic bronchopulmonary aspergillosis: staging as an aid to management. Ann. Intern. Med. 1982; 96 (3): 286–291. DOI:10.7326/0003-4819-96-3-286.; Agarwal R. Allergic bronchopulmonary aspergillosis. Chest. 2009; 135 (3): 805–826. DOI:10.1378/chest.08-2586.; Stevens D.A., Schwartz H.J., Lee J.Y. et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N. Engl. J. Med. 2000; 342 (11): 756–762. DOI:10.1056/NEJM200003163421102.; Agarwal R., Dhooria S., Singh Sehgal I. et al. A randomized trial of itraconazole vs prednisolone in acute-stage allergic bronchopulmonary aspergillosis complicating asthma. Chest. 2018; 153 (3): 656–664. DOI:10.1016/j.chest.2018.01.005.; Stern B.M., Sharma G. Ciliary Dysfunction (Kartagener Syndrome, Primary Ciliary Dyskinesia). StatPearls [Internet]. Treasure Island (FL): Stat Pearls Publishing; 2019.; Barbato A., Frischer T., Kuehni C.E. et al. Primary ciliary dyskinesia: a consensus statement on diagnostic and treatment approaches in children. Eur. Respir. J. 2009; 34 (6): 1264–1276. DOI:10.1183/09031936.00176608.; Noone P.G., Leigh M.W., Sannuti A. et al. Primary ciliary dyskinesia: diagnostic and phenotypic features. Am. J. Respir. Crit. Care. Med. 2004; 169 (4): 459–467. DOI:10.1164/rccm.200303-365OC.; Vanaken G.J., Bassinet L., Boon M. et al. Infertility in an adult cohort with primary ciliary dyskinesia: phenotypegene association. Eur. Respir. J. 2017; 50 (5): pii: 1700314. DOI:10.1183/13993003.00314-2017.; Lucas J.S., Barbato A., Collins S.A. et al. European Respiratory Society guidelines for the diagnosis of primary ciliary dyskinesia. Eur. Respir. J. 2017; 49 (1): pii: 1601090. DOI:10.1183/13993003.01090-2016.; Behan L., Dimitrov B.D., Kuehni C.E. et al. PICADAR: a diagnostic predictive tool for primary ciliary dyskinesia. Eur. Respir. J. 2016; 47 (4): 1103–1112. DOI:10.1183/13993003.01551-2015.; Kennedy M.P., Noone P.G., Leigh M.W. et al. High-resolution CT of patients with primary ciliary dyskinesia. Am. J. Roentgenol. 2007; 188 (5): 1232–1238. DOI:10.2214/AJR.06.0965.; Shah A., Shoemark A., MacNeill S.J. et al. A longitudinal study characterizing a large adult primary ciliary dyskinesia population. Eur. Respir. J. 2016; 48 (2): 441–450. DOI:10.1183/13993003.00209-2016.; Shapiro A.J., Zariwala M.A., Ferkol T. et al. Diagnosis, monitoring, and treatment of primary ciliary dyskinesia: PCD foundation consensus recommendations based on state of the art review. Pediatr. Pulmonol. 2016; 51 (2): 115–132. DOI:10.1002/ppul.23304.; Reiff D.B., Wells A.U., Carr D.H. et al. CT findings in bronchiectasis: limited value in distinguishing between idiopathic and specific types. Am. J. Roentgenol. 1995; 165 (2): 261–267. DOI:10.2214/ajr.165.2.7618537.; Wong C., Jayaram L., Karalus N. et al. Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomized, double-blind, placebocontrolled trial. Lancet. 2012; 380 (9842): 660–667. DOI:10.1016/S0140-6736(12)60953-2.; Serisier D.J., Martin M.L., McGuckin M.A. et al. Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial. JAMA. 2013; 309(12): 1260–1267. DOI:10.1001/jama.2013.2290.; Haworth C.S., Foweraker J.E., Wilkinson P. et al. Inhaled colistin in patients with bronchiectasis and chronic Pseudomonas aeruginosa infection. Am. J. Respir. Crit. Care Med. 2014; 189 (8): 975–982. DOI:10.1164/rccm.2013122208OC.; Serisier D.J., Bilton D., De Soyza A. et al. Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomized, double-blind, placebo-controlled trial. Thorax. 2013; 68 (9): 812–817. DOI:10.1136/thoraxjnl-2013-203207.; Анаев Э.Х. Современные подходы к лечению бронхоэктазии у взрослых. Практическая пульмонология. 2017; (4): 30–38.; Kellett F., Robert N.M. Nebulised 7% hypertonic saline improves lung function and quality of life in bronchiectasis. Respir. Med. 2011; 105 (12): 1831–1835. DOI:10.1016/j.rmed.2011.07.019.; Bilton D., Tino G., Barker A.F. et al. Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomized, controlled trial. Thorax. 2014; 69 (12): 1073–1079. DOI:10.1136/thoraxjnl-2014-205587.; Herrero-Cortina B., Alcaraz V., Vilaro J. et al. Impact of hypertonic saline solutions on sputum expectoration and their safety profile in patients with bronchiectasis: a randomized crossover trial. J. Aerosol. Med. Pulm. Drug Deliv. 2018; 31 (5): 281–289. DOI:10.1089/jamp.2017.1443.; Murray M.P., Pentland J.L., Hill A.T. A randomized crossover trial of chest physiotherapy in non-cystic fibrosis bronchiectasis. Eur. Respir. J. 2009; 34 (5): 1086–1092. DOI:10.1183/09031936.00055509.; Nicolini A., Cardini F., Landucci N. et al. Effectiveness of treatment with high-frequency chest wall oscillation in patients with bronchiectasis. BMC. Pulm. Med. 2013; 13: 21. DOI:10.1186/1471-2466-13-21.; Lee A.L., Hill C.J., Cecins N. et al. Minimal important difference in field walking tests in non-cystic fibrosis bronchiectasis following exercise training. Respir. Med. 2014; 108 (9): 1303–1309. DOI:10.1016/j.rmed.2014.07.006.; Zanini A., Aiello M., Adamo D. et al. Effects of pulmonary rehabilitation in patients with non-cystic fibrosis bronchiectasis: a retrospective analysis of clinical and functional predictors of efficacy. Respiration. 2015; 89 (6): 525–533. DOI:10.1159/000380771.; https://journal.pulmonology.ru/pulm/article/view/1286

Διαθεσιμότητα: https://journal.pulmonology.ru/pulm/article/view/1286
https://doi.org/10.18093/0869-0189-2020-30-1-81-91

BASOPHILE ACTIVATION TEST FOR THE DIAGNOSTICS OF FUNGAL SENSITIZATION IN THE PATIENTS WITH CYSTIC FIBROSIS ; ТЕСТ АКТИВАЦИИ БАЗОФИЛОВ ДЛЯ ДИАГНОСТИКИ МИКОГЕННОЙ СЕНСИБИЛИЗАЦИИ У БОЛЬНЫХ МУКОВИСЦИДОЗОМ

Συγγραφείς: Ya. I. Kozlova, E. V. Frolova, A. E. Uchevatkina, L. V. Filippova, O. V. Aak, T. S. Bogomolova, Yu. V. Borzova, V. R. Makhmutova, T. A. Stepanenko, V. D. Kuznetsov, N. V. Vasilyeva, M. V. Shulgina, N. N. Klimko, Я. И. Козлова, Е. В. Фролова, А. Е. Учеваткина, Л. В. Филиппова, О. В. Аак, Т. С. Богомолова, Ю. В. Борзова, В. Р. Махмутова, Т. А. Степаненко, В. Д. Кузнецов, Н. В. Васильева, М. В. Шульгина, Н. Н. Климко

Πηγή: Medical Immunology (Russia); Том 21, № 5 (2019); 919-928 ; Медицинская иммунология; Том 21, № 5 (2019); 919-928 ; 2313-741X ; 1563-0625 ; 10.15789/1563-0625-2019-5

Θεματικοί όροι: микогенная сенсибилизация, Aspergillus spp, Aspergillus fumigatus, allergic bronchopulmonary aspergillosis, cystic fibrosis, fungal sensitization, аллергический бронхолегочный аспергиллез, муковисцидоз

Περιγραφή αρχείου: application/pdf

Relation: https://www.mimmun.ru/mimmun/article/view/1693/1191; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1693/4511; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1693/4512; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1693/4513; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1693/4514; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1693/4515; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1693/4516; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1693/4517; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1693/4518; Козлова Я.И., Учеваткина А.Е., Бычкова Н.С., Филиппова Л.В., Аак О.В., Пятакова А.В., Фролова Е.В., Давыдова Н.И., Климко Н.Н. Тест активации базофилов в диагностике аллергического бронхолегочного аспергиллеза // Проблемы медицинской микологии, 2016. Т. 18, № 3. С. 7-11.; Красовский С.А., Самойленко В.А., Амелина Е.Л. Муковисцидоз: диагностика, клиника, основные принципы терапии // Пульмонология и аллергология, 2013. № 1. С. 42-46.; Agarwal R., Chakrabarti A., Shah A., Gupta D., Meis J.F., Guleria R., Moss R., Denning D.W. For the ABPA complicating asthma ISHAM working group 2013. Allergic bronchopulmonary aspergillosis: Review of literature and proposal of new diagnostic and classification criteria. Clin. Exp. Allergy, 2013, Vol. 43, no. 8, pp. 850-873.; Baxter C.G., Dunn G., Jones A.M., Webb K., Gore R., Richardson M.D., Denning D.W. Novel immunologic classification of aspergillosis in adult cystic fibrosis. J. Allergy Clin. Immunol., 2013, Vol. 132, no. 3, pp. 560-566.; Baxter C.G., Moore C.B., Jones A.M., Webb A.K., Denning D.W. IgE-mediated immune responses and airway detection of Aspergillus and Candida in adult cystic fibrosis. Chest, 2013, Vol. 143, no. 5, pp. 1351-1357.; Boumiza R., Debard A.L., Monneret G. The basophil activation test by flow cytometry: Recent development in clinical studies, standardization and emerging perspectives. Clin. Mol. Allergy, 2005, no. 3, pp. 9-13.; Chirumbolo S., Vella A., Ortolani R., de Gironcoli M., Solero P., Tridente G., Bellavite P. Differential response of human basophil activation markers: a multiparameter flow cytometry approach. Clin. Mol. Allergy, 2008, no. 6, pp. 12-16.; Chotirmall S.H., McElvaney N.G. Fungi in the cystic fibrosis lung: Bystanders or pathogens? Int. J. Biochem. Cell Biol., 2014, no. 52, pp. 161-173.; Chirumbolo S.H. Basophil activation test in allergy: time for an update? Int. Arch. Allergy Immunol., 2012, no. 158, pp. 99-114.; Chotirmall S.H., Branagan P., Gunaratnam C., McElvaney N.G. Aspergillus/allergic bronchopulmonary aspergillosis in an Irish cystic fibrosis population: A diagnostically challenging entity. Respir. Care, 2012, Vol. 53, no. 8, pp. 1035-1041.; Delhaes L., Monchy S., Fréalle E., Hubans C., Salleron J., Leroy S., Prevotat A., Wallet F., Wallaert B., Dei-Cas E., Sime-Ngando T., Chabé M., Viscogliosi E. The airway microbiota in cystic fibrosis: a complex fungal and bacterial community – implications for therapeutic management. PLoS ONE, 2012, Vol. 7, no. 4, e36313. doi:10.1371/journal.pone.0036313.; Denning D.W., Pashley C., Hartl D., Wardlaw A., Godet C., del Giacco S., Delhaes L., Sergejeva S. Fungal allergy in asthma-state of the art and research needs. Clin. Transl. Allergy. 2014, Vol. 4, p. 14.; Farrell Ph.M., White T.B., Ren Cl.L., Hempstead S.E., Accurso F., Derichs N., Howenstine M., McColley S.A., Rock M., Rosenfeld M., Sermet-Gaudelus I., Southern K.W., Marshall B.C., Sosnay P.R. Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation. J. Pediatr., 2017, Vol. 181, pp. 4-15.; Fillaux J., Bremont F., Murris M., Cassaing S., Rittie J-L., Tetu L., Segonds C., Abbal M., Bieth E., Berry A., Pipy B., Magnaval J-F. Assessment of Aspergillus sensitization or persistent carriage as a factor in lung function impairment in cystic fibrosis patients. Scand. J. Infect. Dis., 2012, Vol. 44, no. 11, pp. 842-847.; Janahi I.A., Rehman A., Al-Naimi A.R. Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Ann. Thorac. Med., 2017, Vol. 12, no. 2, pp. 74-82.; Karasuyama H., Tsujimura Y., Оbata K., Mukai K. Role for basophils in systemic anaphylaxis. Anaphylaxis. Chem. Immunol. Allergy, 2010, Vol. 95, pp. 85-97.; Kang M.G., Song W.J., Park H.K., Lim K.H., Kim S.J., Lee S.Y., Kim S.H., Cho S.H., Min K.U., Chang Y.S. Basophil activation test with food additives in chronic urticaria patients. Clin. Nutr. Res., 2014, Vol. 3, no. 1, pp. 9-16.; Knutsen A.P., Kariuki B., Consolino J.D., Warrier M.R. IL-4 alpha chain receptor (IL-4R alpha) polymorphisms in allergic bronchopulmonary aspergillosis. Clin. Mol. Allergy, 2006, no. 4, p. 3.; Maturu V.N., Agarwal R. Prevalence of Aspergillus sensitization and allergic bronchopulmonary aspergillosis in cystic fibrosis: Systematic review and meta-analysis. Clin. Exp. Allergy, 2015, Vol. 45, no. 12, pp. 1765-1778.; Mircovic B., Lavelle G.M., Abdul Azim A., Helma K., Gargoum F.S., Molloy K., Gernez Y., Dunne K., Renwick J., Murphy P., Moss R.B., Greene C.M., Gunaratnam C., Chotirmall S.H., McElvaney N.G. The Basophil surface marker CD203с identifies Aspergillus species sensitization in patients with cystic fibrosis. J. Allergy Clin. Immunol., 2016, Vol. 137, no. 2, pp. 436-443.; McMahon M.A., Chotirmall S.H., McCullagh B., Branagan P., McElvaney N.G., Logan P.M. Radiological abnormalities associated with Aspergillus colonization in a cystic fibrosis population. Eur. J. Radiol., 2012, Vol. 81, no. 3, pp. e197-202.; Oppenheimer J., Nelson H.S. Skin testing. Ann. Allergy Asthma Immunol., 2006, Vol. 96, no. 2, pp. 6-12.; Peetermans M., Goeminne P., de Boeck C., Dupont L.J. IgE sensitization to Aspergillus fumigatus is not a bystander phenomenon in cystic fibrosis lung disease. Chest, 2014, Vol. 146, pp. 99-100.; Sabino R., Ferreira J.A.G., Moss R.B., Valente J., Veríssimo C., Carolino E., Clemons K.V., Everson C., Banaei N., Penner J., Stevens D.A. Molecular epidemiology of Aspergillus collected from cystic fibrosis patients. J. Cyst. Fibros., 2015, Vol. 14, pp. 474-481.; Stevens D. A., Moss R.B., Kurup V.P., Knutsen A.P., Greenberger P., Judson M.A., Denning D.W., Crameri R., Brody A.S., Light M., Skov M., Maish W., Mastella G. Participants in the Cystic Fibrosis Foundation Consensus Conference. Allergic bronchopulmonary aspergillosis in cystic fibrosis – state of the art: Cystic Fibrosis Foundation Consensus Conference. Clin. Infect. Dis., 2003, Vol. 37, Suppl. 3, pp. 225-264.; Williams C., Ranjendran, R., Ramage G. Pathogenesis of fungal infections in cystic fibrosis. Curr. Fungal Infect. Rep., 2016, Vol. 10, pp. 163-169.; https://www.mimmun.ru/mimmun/article/view/1693

Διαθεσιμότητα: https://www.mimmun.ru/mimmun/article/view/1693
https://doi.org/10.15789/1563-0625-2019-5-919-928

Bronchiectasis a starting point in the diagnosis of allergic bronchopulmonary aspergillosis ; Bronșiectaziile punct de plecare în diagnosticul aspergilozei bronhopulmonare alergice. ; Бронхоэктазы отправная точка в диагностике аллергического бронхолегочного аспергиллеза

Συγγραφείς: Munteanu, Oxana

Πηγή: Bulletin of the Academy of Sciences of Moldova. Medical Sciences; Vol. 63 No. 3 (2019): Medical Sciences; 156-161 ; Buletinul Academiei de Științe a Moldovei. Științe medicale; Vol. 63 Nr. 3 (2019): Ştiinţe medicale; 156-161 ; Вестник Академии Наук Молдовы. Медицина; Том 63 № 3 (2019): Медицина; 156-161 ; 1857-0011

Θεματικοί όροι: bronchiectasis, allergic bronchopulmonary aspergillosis, бронхоэктазы, аллергический бронхолегочный аспергиллез, Bronşiectazii, aspergiloza bronhopulmonară alergică

Περιγραφή αρχείου: application/pdf

Relation: https://bulmed.md/bulmed/article/view/3103/3103; https://bulmed.md/bulmed/article/view/3103

Διαθεσιμότητα: https://bulmed.md/bulmed/article/view/3103

Bronșiectaziile punct de plecare în diagnosticul aspergilozei bronhopulmonare alergice.

Συγγραφείς: Munteanu, O.I.

Πηγή: Buletinul Academiei de Ştiinţe a Moldovei. Ştiinţe Medicale 63 (3) 156-161

Θεματικοί όροι: Bronşiectazii, aspergiloza bronhopulmonară alergică, бронхоэктазы, аллергический бронхолегочный аспергиллез, bronchiectasis, allergic bronchopulmonary aspergillosis

Περιγραφή αρχείου: application/pdf

Relation: https://ibn.idsi.md/vizualizare_articol/89841; urn:issn:18570011

Διαθεσιμότητα: https://ibn.idsi.md/vizualizare_articol/89841

DIAGNOSTIC MARKERS OF ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS IN PATIENTS WITH BRONCHIAL ASTHMA ; ДИАГНОСТИЧЕСКИЕ МАРКЕРЫ АЛЛЕРГИЧЕСКОГО БРОНХОЛЕГОЧНОГО АСПЕРГИЛЛЕЗА У БОЛЬНЫХ БРОНХИАЛЬНОЙ АСТМОЙ

Συγγραφείς: Ya. I. Kozlova, E. V. Frolova, L. V. Filippova, A. E. Uchevatkina, O. V. Aak, G. I. Solovyeva, N. N. Klimko, Я. И. Козлова, Е. В. Фролова, Л. В. Филиппова, А. Е. Учеваткина, О. В. Аак, Г. И. Соловьева, Н. Н. Климко

Πηγή: Medical Immunology (Russia); Том 20, № 4 (2018); 561-570 ; Медицинская иммунология; Том 20, № 4 (2018); 561-570 ; 2313-741X ; 1563-0625 ; 10.15789/1563-0625-2018-4

Θεματικοί όροι: итраконазол, A. fumigatus, allergic bronchopulmonary aspergillosis, asthma, chemokines, cytokines, itraconazole, Aspergillus fumigatus, аллергический бронхолегочный аспергиллез, бронхиальная астма, хемокины, цитокины

Περιγραφή αρχείου: application/pdf

Relation: https://www.mimmun.ru/mimmun/article/view/1564/1051; Климко Н.Н., Козлова Я.И., Хостелиди С.Н., Шадривова О.В., Борзова Ю.В., Васильева Н.В. Распространенность тяжелых и хронических микотических заболеваний в Российской Федерации по модели LIFE program // Проблемы медицинской микологии, 2014. № 1. С. 3-8. [Klimko N.N., Kozlova Ya.I., Khostelidi S.N., Shadrivova О.V., Borzova Yu.V., Vasilyeva N.V. The prevalence of serious and chronic fungal diseases in Russian Federation on LIFE program model. Problemy meditsinskoy mikologii = Problems in Medical Mycology, 2014, no. 1, pp. 3-8. (In Russ.)]; Козлова Я.И., Соболев А.В., Фролова Е.В., Аак О.В., Бурыгина Е.В., Климко Н.Н. Аллергический бронхолегочный аспергиллез у больных бронхиальной астмой // Российский аллергологический журнал, 2015. № 2. С. 37-46. [Kozlova Ya.I., Sobolev A.V., Frolova E.V., Aak O.V., Burygina E.V., Klimko N.N. Allergic bronchopulmonar aspergillosis in asthmatic patients. Rossiyskiy allergologicheskiy zhurnal = Russian Allergology Journal, 2015, no. 2, pp. 37-46. (In Russ.)].; Agarwal R. Severe asthma with fungal sensitization. Curr. Allergy Asthma Rep., 2011, Vol. 11, no. 5, pp. 403-413.; Agarwal R.A., Chakrabarti A., Shah D., Gupta D., Meis J.F., Guleria R., Moss R., Denning D.W. For the ABPA complicating asthma ISHAM working group 2013. Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clinical and Experimental Allergy, 2013, Vol. 43, no. 8, pp. 850-873.; Becerra-Díaz M., Wills-Karp M., Heller N.M. New perspectives on the regulation of type II inflammation in asthma. F1000Res, 2017, Vol. 6, p. 1014.; Carsin A., Romain T., Ranque S., Reynaud-Gaubert M., Dubus J.-C., Mège J.-L., Vitte J. Aspergillus fumigatus in cystic fibrosis: An update on immune interactions and molecular diagnostics in allergic bronchopulmonary aspergillosis. Allergy, 2017, Vol. 72, no. 11, pp. 1632-1642.; Chai R., Liu B., Qi F. IL-31, IL-33, and TSLP expression and relation to severity of asthma and rhinitis in Chinese allergic patients. Int. J. Clin. Exp. Pathol., 2017, Vol. 10, no. 2, pp. 1774-1782.; Chaudhary N., Marr K.A. Impact of Aspergillus fumigatus in allergic airway diseases. Clin. Transl. Allergy, 2011, Vol. 1, no. 1, p. 4.; Chauhan A., Singh M., Agarwal A., Paul N. Correlation of TSLP, IL-33, and CD4+CD25+FOXP3+T regulatory in pediatric asthma. J. Asthma, 2015, Vol. 52, no. 9, pp. 868-872.; Denning D.W., Pashley C., Hartl D., Wardlaw A., Godet C., Del Giacco S., Delhaes L., Sergejeva S. Fungal allergy in asthma-state of the art and research needs. Clin. Transl. Allergy, 2014, Vol. 15, no. 4, p. 14.; Gibson P.G., Wark P.A., Simpson J.L., Meldrum C., Meldrum S., Saltos N., Boyle M. Induced sputum IL-8 gene expression, neutrophil influx and MMP-9 in allergic bronchopulmonary aspergillosis. Eur. Respir. J., 2003, Vol. 21, pp. 582-588.; Goh K.J., Yii A.C.A., Lapperre T.S., Chan A.K., Chew F.T., Chotirmall S.H., Koh M.S. Sensitization to Aspergillus species is associated with frequent exacerbations in severe asthma. J. Asthma Allergy, 2017, Vol. 21, no. 10, pp. 131-140.; Hartl D., Latzin P., Zissel G., Krane M., Krauss-Etschmann S., Griese M. Chemokines indicate allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Am. J. Respir. Crit. Care Med., 2006, Vol. 173, no. 12, pp. 1370-1376.; Hogan C., Denning D.W. Allergic bronchopulmonary aspergillosis and related allergic syndromes. Semin. Respir. Crit. Care Med., 2011, Vol. 32, no. 6, pp. 682-692.; Kennedy J.L., Steinke J.W., Liu L., Negri J., Borish L., Payne S.C. Failure of itraconazole to prevent T-helper type 2 cell immune deviation: Implications for chronic rhinosinusitis. Am. J. Rhinol. Allergy, 2016, Vol. 30, no. 6, pp. 379-384.; Latzin P., Hartl D., Regamey N., Frey U., Schoeni M.H., Casaulta C. Comparison of serum markers for allergicbronchopulmonary aspergillosis in cystic fibrosis. Eur. Respir. J., 2008, Vol. 31, pp. 36-42.; Margalit A., Kavanagh K. The innate immune response to Aspergillus fumigatus at the alveolar surface. FEMS Microbiol. Rev., 2015, Vol. 39, no. 5, pp. 670-687.; Masaki K., Fukunaga K., Matsusaka M., Kabata H., Tanosaki T., Mochimaru T., Kamatani T., Ohtsuka K., Baba R., Ueda S., Suzuki Y., Sakamaki F., Oyamada Y., Inoue T., Oguma T., Sayama K., Koh H., Nakamura M., Umeda A., Kamei K., Izuhara K., Asano K., Betsuyaku T. Characteristics of severe asthma with fungal sensitization. Ann Allergy Asthma Immunol., 2017, Vol. 119, no. 3, pp. 253-257.; McAllister F., Henry A., Kreindler J.L., Dubin P.J., Ulrich L., Steele C., Finder J.D., Pilewski J.M., Carreno B.M., Goldman S.J., Pirhonen J., Kolls J.K. Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogene-alpha and granulocyte colony-stimulating factor in bronchial epithelium: implications for airway inflammation in cystic fibrosis. J. Immunol., 2005, Vol. 175, no. 1, pp. 404-412.; Murdock B.J., Shreiner A.B., McDonald R.A., Osterholzer J.J., White E.S., Toews G.B., Huffnagle G.B. Coevolution of Th1, Th 2, and Th 17 responses during repeated pulmonary exposure to Aspergillus fumigatus conidia. Infect. Immun., 2011, Vol. 79, no. 1, pp. 125-135.; Porter P., Susarla S.C., Polikepahad S., Qian Y., Hampton J., Kiss A., Vaidya S., Sur S., Ongeri V., Yang T., Delclos G.L., Abramson S., Kheradmand F., Corry D.B. Link between allergic asthma and airway mucosal infection suggested by proteinase-secreting household fungi. Mucosal Immunol., 2009, Vol. 2, no. 6, pp. 504-517.; Shah A., Paniabi C. Allergic bronchopulmonary aspergillosis: a perplexing clinical entity. Allergy Asthma Immunology Res., 2016, Vol. 8, no. 4, pp. 282-297.; Wang Y.H., Liu Y.J. Thymic stromal lymphopoietin, OX40-ligand, and interleukin-25 in allergic responses. Clin. Exp. Allergy, 2009, Vol. 39, no. 6, pp. 798-806.; Wark P.A., Hensley M.J., Saltos N., Boyle M.J., Toneguzzi R.C., Epid G.D., Simpson J.L., McElduff P., Gibson P.G. Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: A randomized controlled trial. J. Allergy Clin. Immunol., 2003, Vol. 111, no. 5, pp. 952-257.; Ying S., O’Connor B., Ratoff J., Meng Q., Fang C., Cousins D., Zhang G., Gu S., Gao Z., Shamji B., Edwards M.J., Lee T.H., Corrigan C.J. Expression and cellular provenance of thymic stromal lymphopoietin and chemokines in patients with severe asthma and chronic obstructive pulmonary disease. J. Immunol., 2008, Vol. 181, no. 4, pp. 2790-2798.; https://www.mimmun.ru/mimmun/article/view/1564

Διαθεσιμότητα: https://www.mimmun.ru/mimmun/article/view/1564
https://doi.org/10.15789/1563-0625-2018-4-561-570

Bronchiectases in Children: Overview of Current Clinical Guidelines ; Бронхоэктазы у детей: обзор современных клинических рекомендаций

Συγγραφείς: A. A. Baranov, L. S. Namazova-Baranova, O. I. Simonova, E. A. Vishneva, L. R. Selimzyanova, E. V. Sereda, N. N. Rozinova, E. N. Tzygina, L. K. Katosova, A. V. Lazareva, Yu. V. Gorinova, O. V. Kustova, А. А. Баранов, Л. С. Намазова-Баранова, О. И. Симонова, Е. А. Вишнёва, Л. Р. Селимзянова, Е. В. Середа, Н. Н. Розинова, Е. Н. Цыгина, Л. К. Катосова, А. В. Лазарева, Ю. В. Горинова, О. В. Кустова

Πηγή: Pediatric pharmacology; Том 14, № 1 (2017); 33-42 ; Педиатрическая фармакология; Том 14, № 1 (2017); 33-42 ; 2500-3089 ; 1727-5776

Θεματικοί όροι: хронический бронхит, children, congenital lung malformations, allergic bronchopulmonary aspergillosis, immunodeficiency, computed tomography, cystic fibrosis, primary ciliary dyskinesia, Kartagener’s syndrome, tracheobronchoscopy, chronic bronchitis, дети, врожденные пороки развития легких, аллергический бронхолегочный аспергиллез, иммунодефицит, компьютерная томография, муковисцидоз, первичная цилиарная дискинезия, синдром Картагенера, трахеобронхоскопия

Περιγραφή αρχείου: application/pdf

Relation: https://www.pedpharma.ru/jour/article/view/1499/884; Болезни органов дыхания у детей / Под ред. Рачинского С.В., Таточенко В.К. — М.: Медицина; 1987. — 496 с. [Bolezni organov dykhaniya u detei. Ed by Rachinskii S.V., Tatochenko V.K. Moscow: Meditsina; 1987. 496 p. (In Russ).]; Хронические заболевания легких у детей / Под ред. Розиновой Н.Н., Мизерницкого Ю.Л. — М.: Практика; 2011. — 224 с. [Khronicheskie zabolevaniya legkikh u detei. Ed by Rozinova N.N., Mizernitskii Yu.L. Moscow: Praktika; 2011. 224 p. (In Russ).]; Таточенко В.К. Болезни органов дыхания у детей. Практическое руководство. — М.: ПедиатрЪ; 2012. — 480 с. [Tatochenko VK. Bolezni organov dykhaniya u detei. Prakticheskoe rukovodstvo. Moscow: Pediatr»»; 2012. 480 p. (In Russ).]; Eber E, Midulla F, editors. ERS Handbook of paediatric respiratory medicine. 1st ed. Sheffield, UK: European Respiratory Society; 2013. 719 p.; Floto RA, Haworth CS, editors. Bronchiectasis. European Respiratory Society Monograph, Vol. 52. Sheffield, UK: European Respiratory Society; 2011. 261 p. doi:10.1183/1025448x.erm5210.; uptodate.com [Internet]. UpToDate Evidence-based, physicianauthored clinical decision support resource [cited 2017 Feb 9]. Available from: http://www.uptodate.com.; Pasteur MC, Bilton D, Hill AT; British Thoracic Society Bronchiectasis non-CF Guideline Group. British Thoracic Society guideline for non-CF bronchiectasis. Thorax. 2010;65 Suppl 1:i1–58. doi:10.1136/thx.2010.136119.; Hassan JA, Saadiah S, Roslan H, Zainudin BM. Bronchodilator response to inhaled beta-2 agonist and anticholinergic drugs in patients with bronchiectasis. Respirology. 1999;4(4):423–426. doi:10.1046/j.1440-1843.1999.00215.x.; Ringshausen FC, de Roux A, Diel R, et al. Bronchiectasis in Germany: a population-based estimation of disease prevalence. Eur Respir J. 2015;46(6):1805–1807. doi:10.1183/13993003.00954-2015.; Weycker D, Edelsberg J, Oster G, Tino G. Prevalence and economic burden of bronchiectasis. Clin Pulm Med. 2005;12(4): 205–209. doi:10.1097/01.cpm.0000171422.98696.ed.; Quint JK, Millett ER, Joshi M, et al. Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study. Eur Respir J. 2016:47(1):186–193. doi:10.1183/13993003.01033-2015.; Chang AB, Masel JP, Boyce NC, et al. Non-CF bronchiectasis: clinical and HRCT evaluation. Pediatr Pulmonol. 2003;35(6): 477–483. doi:10.1002/ppul.10289.; Remy-Jardin M, Amara A, Campistron P, et al. Diagnosis of bronchiectasis with multislice spiral CT: accuracy of 3-mm-thick structured sections. Eur Radiol. 2003;13(5):1165–1171. doi:10.1007/s00330-003-1821-z.; Chalmers J, Polverino E, De Soyza A, et al. Heterogeneity in bronchiectasis service provision in Europe: Baseline data from the European bronchiectasis registry (EMBARC). Eur Respir J. 2015;46 Suppl 59:PA374. doi:10.1183/13993003.congress-2015.PA374.; Fujimoto T, Hillejan L, Stamatis G. Current strategy for surgical management of bronchiectasis. Ann Thorac Surg. 2001;72(5): 1711–1715. doi:10.1016/S0003-4975(01)03085-5.; https://www.pedpharma.ru/jour/article/view/1499

Διαθεσιμότητα: https://www.pedpharma.ru/jour/article/view/1499
https://doi.org/10.15690/pf.v14i1.1699

КЛИНИЧЕСКИЕ ОСОБЕННОСТИ АЛЛЕРГИЧЕСКОГО БРОНХОЛЕГОЧНОГО АСПЕРГИЛЛЕЗА У ДЕТЕЙ

Συγγραφείς: Миненкова, Т., Котов, В., Мизерницкий, Ю., Ружицкая, Е., Окунева, Т.

Θεματικοί όροι: аллергический бронхолёгочный аспергиллёз, бронхиальная астма, дети

Περιγραφή αρχείου: text/html

Διαθεσιμότητα: http://cyberleninka.ru/article/n/klinicheskie-osobennosti-allergicheskogo-bronholegochnogo-aspergilleza-u-detey
http://cyberleninka.ru/article_covers/13931284.png

СОЧЕТАНИЕ АЛЛЕРГИЧЕСКОГО БРОНХОЛЕГОЧНОГО АСПЕРГИЛЛЕЗА (ASPERGILLUS TERREUS) И ХРОНИЧЕСКОГО АСПЕРГИЛЛЕЗА ЛЕГКИХ (A.FUMIGATUS). ОПИСАНИЕ КЛИНИЧЕСКОГО СЛУЧАЯ И ОБЗОР ЛИТЕРАТУРЫ

Θεματικοί όροι: ASPERGILLUS SPP, CHRONIC LUNG ASPERGILLOSIS, ХРОНИЧЕСКИЙ АСПЕРГИЛЛЕЗ ЛЕГКИХ, БРОНХИАЛЬНАЯ АСТМА, АЛЛЕРГИЧЕСКИЙ БРОНХОЛЕГОЧНЫЙ АСПЕРГИЛЛЕЗ, ASTHMA, ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS, 3. Good health